Last edition
News about "pharmaceutical regulatory approval"
Sanofi Secures Japan Approval for Subcutaneous Formulation of Sarclisa
Sanofi’s Sarclisa subcutaneous formulation has been approved in Japan for patients with multiple myeloma. The approval is supported by the Phase 3 IRAKLIA study and marks the second global approval after the EU.
Pharmaceutical Regulatory Approval | 22/06/2026 | By News Bureau
Lupin Gets US FDA Tentative Approval for Pitolisant Tablets
US FDA grants tentative approval to Lupin’s Pitolisant Tablets (4.45 mg, 17.8 mg), bioequivalent to Wakix, for approved indications.
Pharmaceutical Regulatory Approval | 25/03/2026 | By News Bureau | 116
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy